Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a significant decrease in short interest during the month of July. As of July 31st, there was short interest totalling 34,600 shares, a decrease of 23.3% from the July 15th total of 45,100 shares. Based on an average daily volume of 29,000 shares, the days-to-cover ratio is currently 1.2 days.

Bioasis Technologies Stock Performance

Shares of OTCMKTS BIOAF opened at $0.12 on Friday. The business's 50 day moving average is $0.13 and its 200-day moving average is $0.17. Bioasis Technologies has a 1-year low of $0.10 and a 1-year high of $0.28.

Bioasis Technologies (OTCMKTS:BIOAF – Get Rating) last posted its earnings results on Tuesday, June 14th. The company reported ($0.01) earnings per share for the quarter. On average, sell-side analysts forecast that Bioasis Technologies will post -0.05 earnings per share for the current fiscal year.

About Bioasis Technologies

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases.

Recommended Stories

• Get a free copy of the StockNews.com research report on Bioasis Technologies (BIOAF)
• 2 Important Retail Stock Battles to Watch
• MarketBeat: Week in Review 8/8 – 8/12
• What Is WallStreetBets and What Stocks Are They Targeting?
• Institutions And Analysts Propel Jack In The Box Higher
• Can You Guess Which EV Stock Is Beating Tesla ?

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.